The Opioid System and Brain Development: Effects of Methadone on the Oligodendrocyte Lineage and the Early Stages of Myelination
暂无分享,去创建一个
[1] M. Nedergaard,et al. White matter astrocytes in health and disease , 2014, Neuroscience.
[2] B. Emery,et al. Mechanisms regulating the development of oligodendrocytes and central nervous system myelin , 2014, Neuroscience.
[3] Panos Roussos,et al. Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalities , 2014, Front. Cell. Neurosci..
[4] L. Amato,et al. Maintenance agonist treatments for opiate-dependent pregnant women. , 2013, The Cochrane database of systematic reviews.
[5] T. Kerr,et al. “Nonmedical” prescription opioid use in North America: a call for priority action , 2013, Substance Abuse Treatment, Prevention, and Policy.
[6] K. Nave,et al. The role of myelin and oligodendrocytes in axonal energy metabolism , 2013, Current Opinion in Neurobiology.
[7] J. Rothstein,et al. Oligodendroglia: metabolic supporters of axons. , 2013, Trends in cell biology.
[8] Greg Freedman,et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010 , 2013, The Lancet.
[9] P. Levounis,et al. Safe Methadone Induction and Stabilization: Report of an Expert Panel , 2013, Journal of addiction medicine.
[10] R. Cunningham,et al. Nonmedical Prescription Opioid and Sedative Use Among Adolescents in the Emergency Department , 2013, Pediatrics.
[11] J. Glanz,et al. National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009. , 2013, Drug and alcohol dependence.
[12] D. Bajic,et al. Morphine-enhanced apoptosis in selective brain regions of neonatal rats , 2013, International Journal of Developmental Neuroscience.
[13] Brady T. West,et al. Medical use, medical misuse, and nonmedical use of prescription opioids: Results from a longitudinal study , 2013, PAIN®.
[14] J. Dieleman,et al. Incidence rates and risk factors of bipolar disorder in the general population: a population‐based cohort study , 2013, Bipolar disorders.
[15] B. Finlay,et al. Modeling Transformations of Neurodevelopmental Sequences across Mammalian Species , 2013, The Journal of Neuroscience.
[16] B. O'dowd,et al. Striatal development involves a switch in gene expression networks, followed by a myelination event: Implications for neuropsychiatric disease , 2013, Synapse.
[17] B. O'dowd,et al. Striatal development involves a switch in gene expression networks, followed by a myelination event: implications for neuropsychiatric disease , 2013 .
[18] J. Dieleman,et al. Annual incidence rate of schizophrenia and schizophrenia spectrum disorders in a longitudinal population-based cohort study , 2013, Social Psychiatry and Psychiatric Epidemiology.
[19] Daniel Rosenblum,et al. Intertwined Epidemics: National Demographic Trends in Hospitalizations for Heroin- and Opioid-Related Overdoses, 1993–2009 , 2013, PloS one.
[20] S. Bilbo,et al. Adolescent Morphine Exposure Affects Long-Term Microglial Function and Later-Life Relapse Liability in a Model of Addiction , 2013, The Journal of Neuroscience.
[21] R. Watts,et al. Neural tract development of infants born to methadone-maintained mothers. , 2012, Pediatric neurology.
[22] A. Eschenroeder,et al. Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ‐opioid‐ and nociceptin/orphanin FQ receptors in cell development: Implications for drug addiction treatment during pregnancy , 2012, Glia.
[23] Scott T. Miller,et al. Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: A phase III analgesic trial for hospitalized sickle cell patients with painful episodes , 2011, American journal of hematology.
[24] D. MacDonald,et al. Accelerated myelination with motor system involvement in a neonate with immediate postnatal onset of seizures and hemimegalencephaly , 2011, Epilepsy & Behavior.
[25] A. Melinder,et al. Prenatal exposure to methadone and buprenorphine: A review of the potential effects on cognitive development , 2011, Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence.
[26] H. Jones,et al. Maternal methadone dose, placental methadone concentrations, and neonatal outcomes. , 2011, Clinical chemistry.
[27] V. Haroutunian,et al. Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophrenia , 2010, Schizophrenia Research.
[28] C. Westin,et al. Corpus Callosum Abnormalities and Their Association with Psychotic Symptoms in Patients with Schizophrenia , 2010, Biological Psychiatry.
[29] R. Bodnar,et al. Sex differences in opioid analgesia, hyperalgesia, tolerance and withdrawal: Central mechanisms of action and roles of gonadal hormones , 2010, Hormones and Behavior.
[30] P. Szeszko,et al. A role for white matter abnormalities in the pathophysiology of bipolar disorder , 2010, Neuroscience & Biobehavioral Reviews.
[31] R. Wesselschmidt,et al. Mu and kappa opioids modulate mouse embryonic stem cell‐derived neural progenitor differentiation via MAP kinases , 2010, Journal of neurochemistry.
[32] C. Sato-Bigbee,et al. Neurotrophin‐3 targets the translational initiation machinery in oligodendrocytes , 2009, Glia.
[33] R. Skoff,et al. Sexual dimorphism in the white matter of rodents , 2009, Journal of the Neurological Sciences.
[34] Michele Tansella,et al. White matter connectivity in bipolar disorder , 2009, International review of psychiatry.
[35] R. Fields,et al. Oligodendrocytes Changing the Rules: Action Potentials in Glia and Oligodendrocytes Controlling Action Potentials , 2008, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[36] Kirstie J. Whitaker,et al. Quantifying development: Investigating highly myelinated voxels in preadolescent corpus callosum , 2008, NeuroImage.
[37] E. Sanchez,et al. Opioid addiction and pregnancy: Perinatal exposure to buprenorphine affects myelination in the developing brain , 2008, Glia.
[38] Ke Zhou,et al. Diffusion tensor imaging of normal white matter maturation from late childhood to young adulthood: Voxel-wise evaluation of mean diffusivity, fractional anisotropy, radial and axial diffusivities, and correlation with reading development , 2008, NeuroImage.
[39] S. Payne,et al. The Immunomodulator FTY720 Has a Direct Cytoprotective Effect in Oligodendrocyte Progenitors , 2007, Journal of Pharmacology and Experimental Therapeutics.
[40] Christopher A Evans,et al. EXTRAPOLATION OF PRECLINICAL PHARMACOKINETICS AND MOLECULAR FEATURE ANALYSIS OF “DISCOVERY-LIKE” MOLECULES TO PREDICT HUMAN PHARMACOKINETICS , 2006, Drug Metabolism and Disposition.
[41] P. Eriksson,et al. Requirement for Id1 in opioid‐induced oligodendrogenesis in cultured adult rat hippocampal progenitors , 2006, The European journal of neuroscience.
[42] Nora D Volkow,et al. Major increases in opioid analgesic abuse in the United States: concerns and strategies. , 2006, Drug and alcohol dependence.
[43] V. Menon,et al. White matter development during childhood and adolescence: a cross-sectional diffusion tensor imaging study. , 2005, Cerebral cortex.
[44] S. Spiegel,et al. Novel role of sphingosine kinase 1 as a mediator of neurotrophin‐3 action in oligodendrocyte progenitors , 2005, Journal of neurochemistry.
[45] Carl-Fredrik Westin,et al. DTI and MTR abnormalities in schizophrenia: Analysis of white matter integrity , 2005, NeuroImage.
[46] Nora I. Perrone-Bizzozero,et al. Altered Myelination of the Hippocampal Formation in Subjects with Schizophrenia and Bipolar Disorder , 2004, Neurochemical Research.
[47] J. Grafman,et al. Human prefrontal cortex: processing and representational perspectives , 2003, Nature Reviews Neuroscience.
[48] D. Grandy,et al. μ-Opioid Receptors: Ligand-Dependent Activation of Potassium Conductance, Desensitization, and Internalization , 2002, The Journal of Neuroscience.
[49] S. Robinson. Effects of perinatal buprenorphine and methadone exposures on striatal cholinergic ontogeny. , 2002, Neurotoxicology and teratology.
[50] S. R. Thornton,et al. Opioid system diversity in developing neurons, astroglia, and oligodendroglia in the subventricular zone and striatum: Impact on gliogenesis in vivo , 2001, Glia.
[51] J. Trimmer,et al. Developmental clustering of ion channels at and near the node of Ranvier. , 2001, Developmental biology.
[52] J. Fuster. The Prefrontal Cortex—An Update Time Is of the Essence , 2001, Neuron.
[53] N. Baumann,et al. Biology of oligodendrocyte and myelin in the mammalian central nervous system. , 2001, Physiological reviews.
[54] L. Solymosi,et al. Unusual pattern of leukoencephalopathy after morphine sulphate intoxication , 2000, Neuroradiology.
[55] C. Gianoulakis,et al. Ontogenesis of Proopiomelanocortin and Its Processing to β-Endorphin by the Fetal and Neonatal Rat Brain , 2000, Neuroendocrinology.
[56] R. Zimmerman,et al. Heroin-induced spongiform leukoencephalopathy: value of diffusion MR imaging. , 2000, Journal of computer assisted tomography.
[57] C. Sato-Bigbee,et al. Different Neuroligands and Signal Transduction Pathways Stimulate CREB Phosphorylation at Specific Developmental Stages Along Oligodendrocyte Differentiation , 1999, Journal of neurochemistry.
[58] M. Oda,et al. Hemimegalencephaly: signal changes suggesting abnormal myelination on MRI , 1998, Neuroradiology.
[59] C. Grandin,et al. Focal seizure-induced premature myelination: speculation from serial MRI , 1998, Neuroradiology.
[60] C. Sato-Bigbee,et al. Purification of Oligodendrocytes and Their Progenitors Using Immunomagnetic Separation and Percoll Gradient Centrifugation , 1998, Current protocols in neuroscience.
[61] Virginia M. Y. Lee,et al. Myelin-Associated Glycoprotein Is a Myelin Signal that Modulates the Caliber of Myelinated Axons , 1998, The Journal of Neuroscience.
[62] P. Knapp,et al. Endogenous opioid system in developing normal and jimpy oligodendrocytes: μ and κ opioid receptors mediate differential mitogenic and growth responses , 1998, Glia.
[63] P. Knapp,et al. μ-Opioid receptor activation enhances DNA synthesis in immature oligodendrocytes , 1996, Brain Research.
[64] C. Adamsbaum,et al. Accelerated myelination in early Sturge-Weber syndrome: MRI-SPECT correlations , 1996, Pediatric Radiology.
[65] S. Robinson,et al. Postnatal methadone exposure doe not prevent prenatal methadone-induced changes in striatal cholinergic neurons. , 1996, Brain research. Developmental brain research.
[66] G. Akkerhuis,et al. Development after prenatal exposure to cocaine, heroin and methadone , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[67] D. Mathalon,et al. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. , 1994, Archives of neurology.
[68] M. M. de Cubas,et al. Children of methadone-dependent women: developmental outcomes. , 1993, The American journal of orthopsychiatry.
[69] K. Hauser,et al. Characterization of opioid-dependent glial development in dissociated and organotypic cultures of mouse central nervous system: critical periods and target specificity. , 1991, Brain research. Developmental brain research.
[70] J. Fok-Seang,et al. Evidence for the ventral origin of oligodendrocyte precursors in the rat spinal cord , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[71] R. Sidman,et al. Role of Myelin Basic Protein in the Formation of Central Nervous System Myelin , 1990, Annals of the New York Academy of Sciences.
[72] S. Hans. Developmental Consequences of Prenatal Exposure to Methadone a , 1989, Annals of the New York Academy of Sciences.
[73] J. Goldman,et al. Spatial and temporal patterns of oligodendrocyte differentiation in rat cerebrum and cerebellum , 1988, The Journal of comparative neurology.
[74] J. Kamholz,et al. Alternative splicing accounts for the four forms of myelin basic protein , 1985, Cell.
[75] F. Stam,et al. LEUCOENCEPHALOPATHY AFTER INHALING "HEROIN" PYROLYSATE , 1982, The Lancet.
[76] S E Poduslo,et al. MYELINATION IN RAT BRAIN: CHANGES IN MYELIN COMPOSITION DURING BRAIN MATURATION 1 , 1973, Journal of neurochemistry.
[77] H. Jones,et al. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009. , 2013, Drug and alcohol dependence.
[78] C. Pantelis,et al. Diseases of white matter and schizophrenia-like psychosis. , 2005, The Australian and New Zealand journal of psychiatry.
[79] G. Hankins,et al. Bidirectional transfer of methadone across human placenta. , 2005, Biochemical pharmacology.
[80] T. Nanovskaya,et al. Transplacental transfer and metabolism of buprenorphine. , 2002, The Journal of pharmacology and experimental therapeutics.
[81] E. Miller,et al. An integrative theory of prefrontal cortex function. , 2001, Annual review of neuroscience.
[82] H. Henkes,et al. Toxic spongiform leucoencephalopathy after inhaling heroin vapour , 1998, European Radiology.
[83] B. Ransom,et al. Electrical coupling, without dye coupling, between mammalian astrocytes and oligodendrocytes in cell culture , 1990, Glia.
[84] R. Reynolds,et al. Expression of the 2′,3′‐cyclic nucleotide 3′‐phosphohydrolase gene and immunoreactive protein in oligodendrocytes as revealed by in situ hybridization and immunofluorescence , 1988, Glia.
[85] P S Bauman,et al. The development of children of drug addicts. , 1986, The International journal of the addictions.
[86] R. Jeremy,et al. A longitudinal study of offspring born to methadone-maintained women. II. Dyadic interaction and infant behavior at 4 months. , 1984, The American journal of drug and alcohol abuse.